High expectations from the draft Bill
The regulation of all retail channels as proposed by the draft Drugs, Medical Devices and Cosmetics Bill 2022 becomes even more…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
DTAB
DTAB recommends granting licence to manufacture, stock new drugs, jabs under clinical trial
Various industry experts and subject experts are of opinion that if the government approves recommendation of DTAB and DCGI, it…
There should be a change in SOP parameters for evaluating FDCs: Dr RK Sanghavi
A sub-committee of DTAB has asked manufacturers of FDCs which were considered irrational by Prof Kokate Committee to present their…
OPPI, FICCI, IPA come together to highlight need for OTC regulations in India
Organise a webinar where experts emphasise the importance of a well-regulated OTC framework to empower patients towards…
KSRPO asks government to bring in centralised drug enforcement department
Highlights need for uniformity in designations and functioning mechanisms of all state FDAs
DCGI instructs industry to follow defined pathways for application submission of rational FDCs
It gives six months to the manufacturers to submit the applications
AIOCD requests government to ban E-pharmacies
The conflict between online pharmacies and offline pharmacies seems to have worsened since the outbreak of the coronavirus…
CDSCO asks industry to submit suggestions on doping drug labels
The Drugs Technical Advisory Board will be reviewing the matter and preparing draft guidelines
Industry welcomes draft New Drugs and Clinical Trials (Amendment) Rules
Recommend measures for more clarity and impact